Physician profile
Robert R Barrett
NPI 1033182134
$864.79
in general payments reported to CMS, 2019-2025
17 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $15.37 · 2021: $136 · 2022: $242 · 2023: $175 · 2024: $79.47 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $355.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $203.57 | 2021-2024 | Lo Loestrin Fe, Liletta |
| Pfizer INC. | $146.07 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $67.83 | 2019-2022 | |
| Organon LLC | $67.75 | 2024-2025 | Nexplanon |
| Astellas Pharma US INC | $65.46 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $55.40 | 2023-2025 | |
| Coopersurgical, INC. | $51.73 | 2019-2022 | |
| Agile Therapeutics, INC. | $41.50 | 2021 | |
| Merck Sharp & Dohme LLC | $27.19 | 2019 | |
| Channel Medsystems, INC. | $26.28 | 2025 | |
| Therapeuticsmd, INC. | $19.01 | 2019 | |
| Millicent US INC | $17.79 | 2025 | Femlyv, Intrarosa |
| Baxter Healthcare | $17.51 | 2021 | |
| Covidien LP | $17.38 | 2019 | |
| Exeltis, USA INC. | $17.06 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $15.17 | 2022 | |
| Meditrina | $8.09 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Barrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.